Cyclodextrin

Event Recap by Tamas Sohayda from CarboHyde PODD 2026 in Boston offered an excellent opportunity to explore the latest developments...

Overview Biologics are transforming modern medicine — but their size, complexity and sensitivity create some of the toughest challenges in...

Abstract JDS364.HCl, an oxime-based reactivator developed for the treatment of organophosphorus nerve agent intoxication, has recently emerged as a promising...

Abstract Cyclodextrins (CDs) are cyclic oligosaccharides made up of α-(1 → 4)-linked d-glucopyranose units and are generally obtained by enzymatic conversion of...

Lille, France, September 30, 2026 Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical...

Abstract Protein-based therapeutics at high-concentrations often face significant development challenges, including high viscosity, limited solubility, poor injectability, and instability concerns....

Abstract Drug permeation across biological membranes is governed by the interplay between diffusional resistances and thermodynamic driving forces. Cyclodextrins (CDs)...

Abstract Poor aqueous solubility is a major cause of solubility-limited absorption and misleading pharmacokinetic outcomes during early oral drug discovery....

Abstract Spray freeze-drying (SFD) is a cutting-edge technique for producing dry powders, ideal for pulmonary drug delivery, owing to its...

Abstract Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal...